Speech-Language Pathologists in Colville, WA Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Brieann Rajewski Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 217 S Hofstetter St, Colville, WA 99114 Phone: 509-684-7800 |
 Kyle P Swanson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 151 Buena Vista Dr, Colville, WA 99114 Phone: 509-684-4539 |
Jessica Leigh Keis Cockerham, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Elep Ave, Colville, WA 99114 Phone: 509-684-2573 |
Ms. Pamela J Worden, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Elep Ave, Colville, WA 99114 Phone: 509-684-2573 Fax: 509-685-2207 |
News Archive
Non-compliance notification from NASDAQ issued to Cardica
Cardica, Inc. (Nasdaq: CRDC) today announced that, on September 2, 2009, it received a notice from the Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) stating that the Company's stock will be delisted from NASDAQ based upon NASDAQ staff's determination that Cardica has not regained compliance with the minimum $10 million stockholders' equity requirement for continued listing on the NASDAQ as stated under NASDAQ Marketplace Rule 5450(b)(1)(A).
Intraoperative RLN monitoring prior to thyroid surgery improves surgical outcomes
Intraoperative recurrent laryngeal nerve (RLN) monitoring has gained popularity with approximately 53 percent of general surgeons and 65 percent of otolaryngologists using intraoperative nerve monitoring in select or all cases.
Reporter's notebook: The tale of Theranos and the mysterious fire alarm
It was November 2014, and I was working on a feature story about a buzzed-about blood-testing company in Silicon Valley that promised to "disrupt" the lab industry with new technology.
Zogenix, Desitin receive MAA approval for SUMAVEL DosePro needle-free delivery system in Denmark
Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH ("Desitin") were granted approval of the Marketing Authorization Application ("MAA") for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system by the Danish Medicines Agency of Denmark.
› Verified 2 days ago
Physical Therapists
Optometrists
Chiropractors
Occupational Therapists
Speech-Language Pathologists
Podiatrists
Audiologists